Cubist Systematic Strategies’s Global Blood Therapeutics, Inc. GBT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-32,834
| Closed | -$2.24M | – | 4984 |
|
|
2022
Q3 | $2.24M | Sell |
32,834
-29,655
| -47% | -$1.64M | 0.01% | 1890 |
|
|
2022
Q2 | $2M | Buy |
62,489
+51,598
| +474% | +$1.51M | 0.01% | 1869 |
|
|
2022
Q1 | $377K | Sell |
10,891
-26,899
| -71% | -$804K | ﹤0.01% | 2703 |
|
|
2021
Q4 | $1.11M | Sell |
37,790
-140,009
| -79% | -$4.34M | 0.01% | 1842 |
|
|
2021
Q3 | $4.53M | Buy |
177,799
+92,896
| +109% | +$2.73M | 0.06% | 515 |
|
|
2021
Q2 | $2.97M | Buy |
84,903
+7,269
| +9% | +$284K | 0.03% | 836 |
|
|
2021
Q1 | $3.16M | Buy |
77,634
+23,095
| +42% | +$1.06M | 0.04% | 714 |
|
|
2020
Q4 | $2.36M | Buy |
54,539
+21,347
| +64% | +$1.05M | 0.03% | 845 |
|
|
2020
Q3 | $1.83M | Sell |
33,192
-18,295
| -36% | -$1.16M | 0.03% | 965 |
|
|
2020
Q2 | $3.25M | Buy |
51,487
+32,906
| +177% | +$2.26M | 0.06% | 539 |
|
|
2020
Q1 | $949K | Sell |
18,581
-4,668
| -20% | -$313K | 0.03% | 869 |
|
|
2019
Q4 | $1.85M | Buy |
23,249
+10,144
| +77% | +$601K | 0.03% | 794 |
|
|
2019
Q3 | $636K | Sell |
13,105
-4,257
| -25% | -$222K | 0.01% | 1179 |
|
|
2019
Q2 | $913K | Buy |
+17,362
| New | +$998K | 0.02% | 1099 |
|
|
2018
Q4 | – | Sell |
-9,410
| Closed | -$358K | – | 2349 |
|
|
2018
Q3 | $358K | Buy |
9,410
+1,308
| +16% | +$57.9K | 0.02% | 1048 |
|
|
2018
Q2 | $366K | Buy |
+8,102
| New | +$369K | 0.02% | 960 |
|
|
2018
Q1 | – | Sell |
-733
| Closed | -$29K | – | 2143 |
|
|
2017
Q4 | $29K | Sell |
733
-5,786
| -89% | -$216K | ﹤0.01% | 1823 |
|
|
2017
Q3 | $202K | Sell |
6,519
-1,686
| -21% | -$47.4K | 0.01% | 1439 |
|
|
2017
Q2 | $224K | Buy |
8,205
+3,991
| +95% | +$119K | 0.01% | 1223 |
|
|
2017
Q1 | $155K | Buy |
+4,214
| New | +$106K | 0.01% | 1278 |
|
|
2016
Q2 | – | Sell |
-5,665
| Closed | -$90K | – | 1937 |
|
|
2016
Q1 | $90K | Buy |
+5,665
| New | +$101K | 0.01% | 1412 |
|
Other funds holding GBT
Cubist Systematic Strategies's GBT Position: Q4 2022 in Review
Cubist Systematic Strategies sold out of Global Blood Therapeutics, Inc. (GBT) in Q4 2022, closing a stake of 32,834 shares — an estimated $2.24M sold.
Cubist Systematic Strategies first reported a position in GBT in Q1 2016 and held it in 21 quarters. The position peaked at $4.53M in Q3 2021. 2 funds tracked by Wall St. Rank hold GBT as of Q4 2022.
- Cubist Systematic Strategies reported no remaining Global Blood Therapeutics, Inc. position as of Q4 2022 after selling out during the quarter.
- Cubist Systematic Strategies sold 32,834 Global Blood Therapeutics, Inc. shares in Q4 2022, an estimated $2.24M.
- Cubist Systematic Strategies first reported a position in Global Blood Therapeutics, Inc. in Q1 2016 and held it in 21 quarters.
- Cubist Systematic Strategies's Global Blood Therapeutics, Inc. position peaked at $4.53M in Q3 2021.
- 2 funds tracked by Wall St. Rank held Global Blood Therapeutics, Inc. as of Q4 2022.
Based on Cubist Systematic Strategies's 13F filing for Q4 2022, filed 14 Feb 2023.